Studies have shown that Semaglutide can help reduce markers of inflammation in patients with arthritis, leading to improvements in joint pain, swelling, and mobility
STEP 4 Trial: Those who continued Semaglutide after 20 weeks lost an additional 7.9% of their weight, while those switched to placebo regained weight
Batch Testing Reports Description & Pharmacodynamics GLP-3 (RT)s unique mechanism of action involves simultaneous activation of: GLP-1 Receptors : Enhances insulin secretion, delays gastric emptying, and promotes satiety
For those planning pregnancy after GLP-1 use, our guide covers GLP-1 considerations around pregnancy and breastfeeding
However, long-term safety and efficacy data remain limited, and most weight loss programs still rely on GLP-1 monotherapy